VISIPAQUE 270
Google image searchProduct monograph
Active ingredient
iodixanol, 550 MG/ML
DIN: 02145766
Dosage form(s): SOLUTION
Route(s) of administration: INTRA-ARTERIAL, INTRAVENOUS
Schedule: Ethical
Company: GE HEALTHCARE CANADA INC
Date: 08-SEP-2021
ATC:
- V08 — CONTRAST MEDIA (ATC, ATC/DDD, )
- V08A — X-RAY CONTRAST MEDIA, IODINATED (ATC, ATC/DDD)
- V08AB — Watersoluble, nephrotropic, low osmolar X-ray contrast media (ATC, ATC/DDD)
- V08AB09 — IODIXANOL (ATC/DDD)
Reference brand drug: Visipaque
Pharmaceutical standard: USP
